Flexion TherapeuticsRecent Data Breaches and Security Report

https://flexiontherapeutics.com  ᛫ 
Last updated October 26, 2018

Company Details

Company Overview

Flexion Therapeutics is an American pharmaceutical company based in Burlington, Massachusetts that is developing reformulated sustained release versions of existing drugs that are intended to be injected into the joint to treat osteoarthritis.It was founded around 2007 by two former Eli Lilly & Co. executives and went public in 2014.In November 2016 the FDA accepted Flexion's New Drug Application for FX006, a sustained-release formulation of triamcinolone acetonide (a corticosteroid), branded "Zilretta".

Valuation

$930,117,500

Employees

251

CEO

Location

Burlington, MA, United States.

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Flexion Therapeutics

subscribe to data breach notifications

More Security Reports

Braskem Logo
Braskem
›
Core Mark Logo
Core Mark
›
Halliburton Logo
Halliburton
›

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Flexion Therapeutics

Get full security report ›

More Security Reports

Flexion Therapeutics Logo
Braskem
›
Flexion Therapeutics Logo
Core Mark
›
Flexion Therapeutics Logo
Halliburton
›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.